Ritu Lal PhD MS
individual
About
Ritu Lal is a biotech operator and drug-development executive with a pharmacology background spanning Abbott and Roche. She founded GEn1E Lifesciences in 2018 around University of Maryland technology for inflammatory and rare diseases, and a December 11, 2024 company press release identifies her as CEO and co-founder. Public conference materials also list her as CEO presenter for GeoVax Labs, indicating a senior operating role in another biotech company.
Areas of interest
biotechdrug developmentinflammatory diseasesrare diseasesage-related diseasesprecision therapiesAI in drug developmentvaccinesimmuno-oncologybioinformaticsautoimmune disease